Logo image
Risk management recommendations and patient acceptance vary with high-risk breast lesions
Journal article   Peer reviewed

Risk management recommendations and patient acceptance vary with high-risk breast lesions

Anna C Beck, Sophia L Fu, Junlin Liao, Amani Bashir, Sonia L Sugg, Lillian M Erdahl, Ronald J Weigel and Ingrid M Lizarraga
The American journal of surgery, Vol.223(1), pp.94-100
2021
DOI: 10.1016/j.amjsurg.2021.07.020
PMID: 34325908

View Online

Abstract

Lobular carcinoma in situ (LCIS), atypical ductal and lobular hyperplasia (AH) increase breast cancer risk. We examined risk management recommendations (RMR) and acceptance in AH/LCIS. All patients with AH/LCIS on core needle biopsy from 2013 to 2016 at our institution were identified; cancer patients were excluded. Univariate and multivariate analysis examined factors associated with management. 98 % of patients were evaluated by breast surgeons and 53 % underwent risk model calculation (RC). 77 % had new RMR. RMR of MRI screening (MRI), genetic counselling (GC) and medical oncology (MO) referral were 41 %, 18 %, 77 %, respectively. MRI screening was more likely recommended in those with strong family history (p = 0.01), and high RC (p < 0.001). Uptake of at least one RMR did not occur in 84 % of patients. Use of RC correlated with MO acceptance (p = 0.049). Diagnosis of atypia has the potential to change risk management for most, however only 16 % of patients accepted all RMR. •77 % of patients had new risk management recommendations with diagnosis of AH/LCIS.•84 % of patients did not accept at least one risk reducing recommendation.•Using a risk model was associated with uptake of medical oncology referral.
Atypical hyperplasia LCIS Risk reduction The gail model Tyrer-cuzick model

Details

Metrics

Logo image